Padavala Sudha, Pope Nicole, Baker Philip, Crocker Ian
Maternal and Fetal Health Research Centre, St. Mary's Hospital, Manchester, United Kingdom.
J Soc Gynecol Investig. 2006 Jan;13(1):40-7. doi: 10.1016/j.jsgi.2005.09.010. Epub 2005 Nov 21.
Human umbilical vascular endothelial cells (HUVECs), seeded on Matrigel (BD Biosciences, Bedford, UK), undergo an angiogenic-like process. We hypothesized that placental explants from normal pregnancies, maintained in cultures of different oxygen, would liberate factors that could be measured in this system. We further tested the angiogenic potential of placentae from intrauterine growth-restricted (IUGR) pregnancies and the effects of vascular endothelial growth factor (VEGF) blockade.
Placental villous explants were maintained in culture at 3% and 20% O2. The resultant media was added to HUVECs seeded on 80% Matrigel. Cells were incubated at 6% O2 in accordance with the natural placental environment. After 6 hours, cells were fixed and stained and the length and number of tubules measured by morphometric imaging. Finally, VEGF and soluble VEGF receptor (sVEGFR-1) were recorded in the explant conditioned media.
Within the angiogenic assay, recombinant human VEGF significantly enhanced tubule outgrowth (branching and elongation) and this effect was blocked with neutralising antibody. Compared to 20% O2, media of placental explants conditioned at 3% O2 significantly encouraged tubule length and numbers. Again this affect was ablated by VEGF blockade. In cases of IUGR, conditioned media at 3% O2 showed a significant reduction in tubule growth. This was paralleled by a decline in available VEGF brought about an exaggeration in liberated sVEGFR-1. Notably, venous cord serum from IUGR pregnancies showed a similar elevation in sVEGFR-1.
Under restricted oxygen, placental angiogenic potential is suppressed in IUGR pregnancies through the overproduction of placental sVEGFR-1. This reduction may discourage normal placental vascularization and impact on fetal development.
接种于基质胶(英国贝德福德BD生物科学公司)上的人脐血管内皮细胞(HUVECs)会经历类血管生成过程。我们推测,来自正常妊娠的胎盘外植体在不同氧气浓度的培养条件下,会释放出可在该系统中检测到的因子。我们进一步测试了宫内生长受限(IUGR)妊娠胎盘的血管生成潜力以及血管内皮生长因子(VEGF)阻断的影响。
胎盘绒毛外植体在3%和20%氧气浓度下进行培养。将所得培养基添加到接种于80%基质胶上的HUVECs中。细胞按照胎盘自然环境在6%氧气浓度下孵育。6小时后,细胞固定、染色,并通过形态计量成像测量小管的长度和数量。最后,记录外植体条件培养基中的VEGF和可溶性VEGF受体(sVEGFR-1)。
在血管生成试验中,重组人VEGF显著促进小管生长(分支和伸长),且这种作用被中和抗体阻断。与20%氧气浓度相比,3%氧气浓度条件下培养的胎盘外植体培养基显著促进小管长度和数量增加。同样,这种作用也被VEGF阻断消除。在IUGR病例中,3%氧气浓度条件下的条件培养基显示小管生长显著减少。这与可用VEGF的下降同时出现,导致释放的sVEGFR-1增加。值得注意的是,IUGR妊娠的脐静脉血清中sVEGFR-1也有类似升高。
在氧气受限的情况下,IUGR妊娠中胎盘的血管生成潜力因胎盘sVEGFR-1的过度产生而受到抑制。这种减少可能不利于正常胎盘血管形成,并影响胎儿发育。